Notice of Pre-Application Webinar for the NIH Common Fund Acute to Chronic Pain Signatures Program

Notice Number: NOT-RM-18-021

Key Dates
Release Date: September 04, 2018

Related Announcements

RFA-RM-18-031

RFA-RM-18-032

RFA-RM-18-033

RFA-RM-18-034

RFA-RM-18-035

Issued by
Office of Strategic Coordination (Common Fund)

Purpose

The NIH will hold a pre-application Q&A webinar for the Acute to Chronic Pain Signatures Program (https://commonfund.nih.gov/pain).

NIH staff will discuss the following funding opportunities and answer questions from prospective applicants.

Data Integration and Resource Center (DIRC) for Common Fund Acute to Chronic Pain Signatures Program (U54) Clinical Trial Optional RFA-RM-18-031

Omics Data Generation Centers (ODGCs) for Common Fund Acute to Chronic Pain Signatures Program (U54) Clinical Trial Optional RFA-RM-18-032

Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Pain from Musculoskeletal Trauma (UM1) Clinical Trials Optional RFA-RM-18-033

Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain (UM1) Clinical Trials Optional RFA-RM-18-034

Clinical Coordination Center for Common Fund Acute to Chronic Pain Signatures (A2CPS) Program (U24) Clinical Trials Optional RFA-RM-18-035

Webinar Information:

Date/Time: September 6, 2018 from 2pm-4pm EDT

To join the event as an attendee

-------------------------------------------------------

1. Go to https://nih.webex.com/nih/onstage/g.php?MTID=e5b0706c3da9da75c94a8d1faaa03ca17

2. Click "Join Now".

-------------------------------------------------------

To join the audio conference only

-------------------------------------------------------

Call-in toll number (US/Canada): 1-650-479-3208

Global call-in numbers: https://nih.webex.com/nih/globalcallin.php?serviceType=EC&ED=708256127&tollFree=0

Access code: 624 155 354

Inquiries

Please direct all inquiries to:

Nic Johnson
National Institute on Drug Abuse
Telephone: 301-443-3482
Email: [email protected]